Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
05/25/2011 | EP1497326B1 Prothrombin activating protein |
05/25/2011 | EP1478666B1 Dermopharmaceutically and cosmetically active oligopeptides |
05/25/2011 | EP1425035B1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
05/25/2011 | EP1366077B1 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST |
05/25/2011 | EP1358341B1 Methods for generating resistance against cgmmv in plants |
05/25/2011 | EP1345959B1 Membrane scaffold proteins |
05/25/2011 | EP1183330B1 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN |
05/25/2011 | EP0959896B1 Method of producing secreted truncated variants of human thyrotropin receptor |
05/25/2011 | CN1993039B Method for making plants having improved growth characteristics |
05/25/2011 | CN1863501B Peptide-based conditioners and colorants for hair, skin, and nails |
05/25/2011 | CN1786031B Glucagon kind polypeptide-1 analogue, its preparation method and application |
05/25/2011 | CN1777807B Method of screening inhibitor by using induction of interleukin 18 production by keratinocyte, and screening kit |
05/25/2011 | CN1772897B Cell factor with several functions |
05/25/2011 | CN102076860A Method of producing yeast biomass |
05/25/2011 | CN102076858A Novel bacillus thuringiensis gene with lepidopteran activity |
05/25/2011 | CN102076855A Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life |
05/25/2011 | CN102076713A Improved fibronectin-based binding molecules and uses thereof |
05/25/2011 | CN102076712A Novel canola protein isolate |
05/25/2011 | CN102076711A Novel bacillus thuringiensis gene with lepidopteran activity |
05/25/2011 | CN102076710A Novel bacillus thuringiensis gene with lepidopteran activity |
05/25/2011 | CN102076709A Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184: insecticidal proteins and methods for their use |
05/25/2011 | CN102076708A New enzymatic active enzyme against clostridium |
05/25/2011 | CN102076705A Purification of modified cytokines |
05/25/2011 | CN102076660A Sulfonamide compound or salt thereof |
05/25/2011 | CN102076356A Attenuated pestivirus |
05/25/2011 | CN102076353A Derivatised hybrid peptides of amylin and salmon calcitonin |
05/25/2011 | CN102076351A Pharmaceutical agent for promoting functional regeneration of damaged tissue |
05/25/2011 | CN102076350A Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation |
05/25/2011 | CN102071214A Construction, expression and purification of human cystatin C eucaryon expression vector |
05/25/2011 | CN102071206A Adeno-associated virus capsid protein gene, corresponding protein and application of protein |
05/25/2011 | CN102071205A Specific antigen of clonorchis sinensis and application thereof |
05/25/2011 | CN102071188A Rav2p gene cloning and expressing method in Saccharomyces cerevisiae |
05/25/2011 | CN102071170A Monoclonal antibody capable of resisting heavy metal copper and preparation method thereof |
05/25/2011 | CN102070714A Method for separating and purifying recombined proserum |
05/25/2011 | CN102070713A Process for purifying Exendin-4 in Esherichia coli through one-step chromatography |
05/25/2011 | CN102070712A VEGF-A (vascular endothelial growth factor-A) protein and use thereof |
05/25/2011 | CN102070711A Tissue factor pathway inhibitor (TFPI), preparation method thereof and application thereof |
05/25/2011 | CN102070710A Specific GRA2a (Glycine Rich Antigen)-type antigenic protein of clonorchis sinensis and application thereof |
05/25/2011 | CN102070709A Plant transcription factor WRKY protein and coding genes and application thereof |
05/25/2011 | CN102070708A Protein BnL1L related to seed fatty acid synthesis as well as encoding gene and applications thereof |
05/25/2011 | CN102070707A Protein BnLEC1 related to seed fatty acid synthesis as well as encoding gene and applications thereof |
05/25/2011 | CN102070706A Protein AtL1L related to seed fatty acid synthesis as well as encoding gene and applications thereof |
05/25/2011 | CN102070705A Plant stress tolerance-relevant protein TaFbox2, coding gene and application thereof |
05/25/2011 | CN102070704A Entire gene sequence of severe fever with thrombocytopenia syndrome virus (SFTSV) and application |
05/25/2011 | CN102070703A Methods for preparing purified daptomycin |
05/25/2011 | CN102070148A Synthesis method and application of mono-disperse micron-scale spherical mesoporous silicon oxide MCM-41 |
05/25/2011 | CN102068688A Application of mechno-growth factor and E peptide thereof to preparation of medicaments and materials for treating osteoporosis or bone defect |
05/25/2011 | CN101597267B Melamine hapten, antigen and preparation method and applications thereof |
05/25/2011 | CN101481701B Preparation of phycoerythrocyanin fluorescent protein combined with phycoerythrobilin |
05/25/2011 | CN101481700B Preparation of phycoerythrocyanin fluorescent protein combined with phycoerythrobilin |
05/25/2011 | CN101481692B Non-blood serum preparation of recombinant human blood coagulation factor IX |
05/25/2011 | CN101475951B Preparation of streptavidin labeled phycocyanin fluorescent protein combined with phycoerythrobilin |
05/25/2011 | CN101475526B Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
05/25/2011 | CN101265296B Reptile cathelicidin antibiotic peptide and derivatives, and application thereof |
05/25/2011 | CN101230097B Hepatitis c virus hypervariable region 1 antigen and its use in preparation of hepatitis c virus detection reagent |
05/25/2011 | CN101185759B Anti-angiogene compositions and methods of use |
05/25/2011 | CN101120015B Interleukin-15 antagonist peptide |
05/25/2011 | CN101100666B Human TCRVbeta7.1_H3F7 gene and its screening method and application |
05/25/2011 | CN101052651B Caspase-2 inhibitors and their biological applications |
05/24/2011 | US7947873 Compositions and methods for regulation of plant gamma-tocopherol methyltransferase |
05/24/2011 | US7947872 Nucleotide sequences involved in plant disease resistance |
05/24/2011 | US7947868 Precise breeding—marker-free transformation |
05/24/2011 | US7947822 HIV vaccines based on Env of multiple clades of HIV |
05/24/2011 | US7947810 Kits for diagnosing a hypophosphatemic disorder |
05/24/2011 | US7947807 Method for obtaining G protein-coupled receptor (GPCR) diffraction-quality crystals employing a monoclonal antibody that binds to the third intracellular loop (IL3) |
05/24/2011 | US7947806 Mussel bioadhesive |
05/24/2011 | US7947805 BCMA polypeptides and uses thereof |
05/24/2011 | US7947804 Vesicle trafficking proteins |
05/24/2011 | US7947655 Methods for making proteins containing free cysteine residues |
05/24/2011 | US7947651 Secreted frizzled related protein, sFRP, fragments and methods of use thereof |
05/24/2011 | US7947650 Article of manufacture |
05/24/2011 | US7947649 Liquid buffered GDF-5 formulations |
05/24/2011 | US7947647 Synthetic mimics of mammalian cell surface receptors: method and compositions |
05/24/2011 | US7947511 Intensified neutral loss tags and use thereof in mass spectrometry |
05/24/2011 | US7947493 Expression vector comprising encephalomyocarditis viral protein for use as tool in designing agents which prevent or treat viral infection; viricides |
05/24/2011 | US7947474 Nucleotide sequences coding cytokine receptor for identifying modulators for treating blood disorders associated with cancer treatment |
05/24/2011 | US7947473 Methods for expression and purification of pegylated recombinant human growth hormone containing a non-naturally encoded keto amino acid |
05/24/2011 | US7947472 An expression vector comprising a sequence of human DNA encoding vascular endothelial growth factor-D (VEGF-D) or a fragment having the biological activity of VEGF-D, inserted into a mammalian expression vector |
05/24/2011 | US7947470 Comprises organic cation transporter polypeptide for use in diagnostic, prevention and treatment of metabolic and cell proliferative disorders |
05/24/2011 | US7947469 Protein comprising receptor nucleotide sequences associated with viral binding and/or infection for use in prevention and treatment of viral and autoimmune diseases; viricides |
05/24/2011 | US7947466 Fluorescence based screening assays are provided that allow for the for identification of agents that selectively bind to a ligand-gated ion channels (LGIC); fluorescence resonance energy transfer (FRET) |
05/24/2011 | US7947463 Diagnosing cancer; measure antibody inhibitor, compare to control, reduced amounts of inhibitor indicates receptivity to cancer |
05/24/2011 | US7947462 Methods for identifying Kremen polypeptide binding partners |
05/24/2011 | US7947460 Diagnosing/prognosing nut allergies; immunodiagnostics |
05/24/2011 | US7947459 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
05/24/2011 | US7947452 Oligonucleotides originating from sequences coding for the surface component of PTLV envelope proteins and their uses |
05/24/2011 | US7947291 Modified surface antigen |
05/24/2011 | US7947290 Protease-resistant modified SEB and vaccine containing the same |
05/24/2011 | US7947289 Multimeric protein toxins to target cells having multiple identifying characteristics |
05/24/2011 | US7947288 Viral particles encoding multifunctional cytokines |
05/24/2011 | US7947287 Peptides for the treatment of cancer associated with the human papilloma virus (HPV) and other epithelial tumors |
05/24/2011 | US7947281 Chimeric proteins that induce effects directed against viruses |
05/24/2011 | US7947276 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
05/24/2011 | US7947275 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth |
05/24/2011 | US7947272 Using mixture comprising inhibitors of CD4, CD25 and interleukin induction as tool in reducing immune response to tissue graft; preventing transplant rejection |
05/24/2011 | US7947264 TGF-β3 mutants |
05/24/2011 | CA2549985C Formulations and methods for denaturing proteins |
05/24/2011 | CA2459251C Novel nucleic acid sequences and their use in methods for achieving pathogen resistance in plants |
05/24/2011 | CA2440596C Soluble heterodimeric cytokine receptor |
05/24/2011 | CA2434059C Constitutive promoter from arabidopsis |